NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON 5-ALPHA-REDUCTASE INHIBITORS AND USES OF SAME

摘要

The invention relates to a pharmaceutical composition based on at least one 5-alpha-reductase inhibitor as an active substance, which is intended to be administered subcutaneously. The inventive composition is characterised in that it takes the form of a non-biodegradable implant and in that it enables the prolonged release of active substances.